Biotech Growth Trust (The) (BIOG)

Sector:

Investment Firms

Index:

FTSE Small Cap

1,000.00p
   
  • Change Today:
      14.00p
  • 52 Week High: 1,024.00p
  • 52 Week Low: 718.00p
  • Currency: UK Pounds
  • Shares Issued: 33.37m
  • Volume: 38,687
  • Market Cap: £333.72m
  • RiskGrade: 135

Shire Chairman sells shares following 'excellent' 2013 results

Date: Friday 21 Feb 2014

LONDON (ShareCast) - Shire's Chairman, Matthew Emmens, has sold 36,100 shares in the biopharmaceutical company following its ‘excellent’ results for 2013.

Emmens disposed of the shares at 3,314.85p each for a total of just under £1.2m shares.

After a pick-up in earnings growth in the fourth quarter, the group beat forecasts for the full-year. Revenues during the quarter rose 12% to $1.33bn, helped by strong growth in product sales of Vyvanse, Lialda/Mezavant, Vpriv and Firazyr.

Revenues in 2013 rose by 12% to $4.76bn, while the company raised its full-year dividend by 15% to 19.93 cents. Shire also said that it expects to deliver a similar level of earnings growth in 2014.

Mark Bristow, the long-time Chief Executive of Randgold Resources, has sold off 40,000 shares in the FTSE 100-listed precious metals miner.

The 4,716p-a-share sale saw Bristow make the most of the huge surge in the company's share price during the past five weeks, during which time it has soared around 1,200p after the group predicted its output would rise over the next five years.

Bristow hailed 2013 as one of the company's best ever years as it reported record gold production, up 15% on the previous year.

The miner predicted that 2014 would see a production increase of between 25% and 30%, largely driven by the progress being made at its Loulo-Gounkoto and Kibali sites.

The £1.9m deal reduced the director's holding to 714,963 shares, equal to 0.77% of the group's issued share capital.


Top Director Buys

BAE Systems (BA.)
Director name: Mr Chris Grigg
Amount purchased: 24,555 @ 406.38p
Value: £99,787

Wood Group (John) (WG.)
Director name: Mr Jeremy Wilson
Amount purchased: 10,000 @ 743.00p
Value: £74,300

Terra Capital (TCA)
Director name: Mr Filip Montfort
Amount purchased: 65,000 @ $0.77
Value: $50,050

Biotech Growth Trust (The) (BIOG)
Director name: Mr Peter Keen
Amount purchased: 5,000 @ 514.29p
Value: £25,714

Informa (INF)
Director name: Mr Derek Mapp
Amount purchased: 4,438 @ 529.76p
Value: £23,511


Top Director Sells

Randgold Resources Ltd. (RRS)
Director name: Dr D Mark Bristow
Amount sold: 40,000 @ 4,716.00p
Value: £1,886,400

Shire Plc (SHP)
Director name: Mr Matthew Emmens
Amount sold: 36,100 @ 3,314.85p
Value: £1,196,661

Allocate Software (ALL)
Director name: Mr Ian Bowles
Amount sold: 476,968 @ 116.00p
Value: £553,283

Informa (INF)
Director name: Mr Derek Mapp
Amount sold: 4,438 @ 529.68p
Value: £23,507

Morgan Advanced Materials (MGAM)
Director name: Mr Paul Andrew Boulton
Amount sold: 7,000 @ 327.62p
Value: £22,933

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

BIOG Market Data

Currency UK Pounds
Share Price 1,000.00p
Change Today 14.00p
% Change 1.42 %
52 Week High 1,024.00p
52 Week Low 718.00p
Volume 38,687
Shares Issued 33.37m
Market Cap £333.72m
RiskGrade 135

BIOG Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.92% above the market average27.92% above the market average27.92% above the market average27.92% above the market average27.92% above the market average
22.97% below the sector average22.97% below the sector average22.97% below the sector average22.97% below the sector average22.97% below the sector average
Price Trend
78.96% above the market average78.96% above the market average78.96% above the market average78.96% above the market average78.96% above the market average
89.73% above the sector average89.73% above the sector average89.73% above the sector average89.73% above the sector average89.73% above the sector average
Income Not Available
Growth
56.63% below the market average56.63% below the market average56.63% below the market average56.63% below the market average56.63% below the market average
43.79% below the sector average43.79% below the sector average43.79% below the sector average43.79% below the sector average43.79% below the sector average

BIOG Dividends

No dividends found

Trades for 15-May-2024

Time Volume / Share Price
16:35 9,465 @ 1,000.00p
16:35 44 @ 1,000.00p
16:35 98 @ 1,000.00p
16:35 251 @ 1,000.00p
16:35 2,687 @ 1,000.00p

Top of Page